Screener
Lexicon Pharmaceuticals LXRX Business Segments — Gain (Loss) on Extinguishment of Debt
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| General and administrative | 6,964 | 6,466 | 13,408 | 14,292 |
| Other segment expense (1) | 3,336 | 3,271 | 6,414 | 6,072 |
| Total operating expenses | 27,232 | 25,130 | 49,330 | 52,071 |
| (Loss) income from operations | (26,540) | 3,736 | (27,536) | (21,943) |
| Interest and other expense | (2,609) | (2,318) | (4,199) | (4,153) |
| Interest and other income | 1,723 | 1,834 | 3,266 | 4,053 |
| Loss on early extinguishment of debt | (4,349) | — | (4,349) | — |
| Net (loss) income | $(31,775) | $3,252 | $(32,818) | $(22,043) |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's business segments — gain (loss) on extinguishment of debt?
- Lexicon Pharmaceuticals (LXRX) reported business segments — gain (loss) on extinguishment of debt of -$4.35M in Q2 2026.
- What does business segments — gain (loss) on extinguishment of debt mean?
- This metric represents the net financial impact resulting from the early retirement or modification of debt obligations within a specific business segment. It captures the difference between the reacquisition price of the debt and its net carrying amount, reflecting the impact of debt restructuring activities on segment-level profitability. Investors monitor this to assess the cost-efficiency of capital structure management and the impact of non-operating financial events on segment performance.
Ask your AI about Lexicon Pharmaceuticals's business segments — gain (loss) on extinguishment of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude